...
机译:Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab
Earle A Chiles Research Institute, Providence Cancer Institute;
Shimadzu Bioscience Research Partnership;
Medical Data Research Center, Providence St Joseph Health;
CTLA-4 antigen; biomarkers; immunotherapy; melanoma; translational medical research; tumor;